Bridgewater Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Buy
6,228
+1,592
+34% +$74.2K 0.02% 389
2025
Q4
$214K Sell
4,636
-756
-14% -$37.5K 0.01% 430
2025
Q3
$267K Sell
5,392
-828
-13% -$40K 0.02% 374
2025
Q2
$307K Sell
6,220
-1,053
-14% -$53.8K 0.02% 332
2025
Q1
$391K Buy
+7,273
New +$394K 0.03% 275

Other funds holding SNY

Bridgewater Advisors's SNY Position: Q1 2026 in Review

Bridgewater Advisors increased its Sanofi (SNY) stake by 34% in Q1 2026, buying an estimated $74.2K and bringing the position to 6,228 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #389.

Bridgewater Advisors first reported a position in SNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $391K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Bridgewater Advisors held 6,228 shares of Sanofi worth $264K as of Q1 2026.
  • Bridgewater Advisors bought 1,592 Sanofi shares in Q1 2026, an estimated $74.2K.
  • Sanofi made up 0.02% of Bridgewater Advisors's portfolio in Q1 2026, its #389 holding.
  • Bridgewater Advisors first reported a position in Sanofi in Q1 2025 and has held it in 5 quarters since.
  • Bridgewater Advisors's Sanofi position peaked at $391K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.